Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation
Clinical Diagnostic Laboratory Immunology · 2000-07 · 7 (4) · 540-548
DOI: 10.1128/cdli.7.4.540-548.2000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Diagnostic Laboratory Immunology, 2000-07. Verfasst von J L Fahey und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Los Angeles, USA. jlfahey@microimmun.medsch.ucla.edu. Hauptthemen laut MEDLINE: Biomarkers, Immune System, Program Development. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
An external evaluation program for measuring the performance of laboratories testing for cytokines and immune activation markers in biological fluids was developed. Cytokines, chemokines, soluble cytokine receptors, and other soluble markers of immune activation (CSM) were measured in plasma from a healthy human immunodeficiency virus (HIV)-seronegative reference population and from HIV-seropositive individuals as well as in supernatant fluids from in vitro-stimulated human immune cells. The 14 components measured were tumor necrosis factor (TNF) alpha, gamma interferon, interleukin-1 (IL-1), IL-2, IL-4, IL-6, IL-10, Rantes, MIP-Ia, MIP-Iβ, soluble TNF receptor II, soluble IL-2 receptor alpha, β 2 -microglobulin, and neopterin. Twelve laboratories associated with the Adult and Pediatric AIDS Clinical Trial Groups participated in the study. The performance features that were evaluated included intralaboratory variability, interlaboratory variability, comparison of reagent sources, and ability to detect CSM in the plasma of normal subjects as well as the changes occurring in disease. The principal findings were as follows: (i) on initial testing, i.e., before participating in the program, laboratories frequently differed markedly in their analytic results; (ii) the quality of testing of a CSM in individual participating laboratories could be assessed; (iii) most commercial kits allowed distinction between normal and abnormal plasma CSM levels and between supernatants of stimulated and unstimulated cells; (iv) different sources of reagents and reference standards frequently provided different absolute values; (v) inexperienced laboratories can benefit from participating in the program; (vi) laboratory performance improved during active participation in the program; and (vii) comparability between analyses conducted at different sites can be ensured by an external proficiency testing program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California, Los Angeles, USA. jlfahey@microimmun.medsch.ucla.edu
Förderung
- NIAID NIH HHS
Zitieren
APA
Fahey, J. L., Aziz, N., Spritzler, J., Plaeger, S., Nishanian, P., Lathey, J. L., Seigel, J., Landay, A. L., Kilarui, R., Schmitz, J. L., White, C., Wara, D. W., Akridge, R., Cutili, J., Douglas, S. D., Reuben, J., Shearer, W. T., Nokta, M., Polland, R., …, & Waxdal, M. (2000). Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation. Clinical Diagnostic Laboratory Immunology, 7(4), 540-548. https://doi.org/10.1128/cdli.7.4.540-548.2000
Vancouver
Fahey JL, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey JL, et al. Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation. Clinical Diagnostic Laboratory Immunology. 2000;7(4):540-548. doi:10.1128/cdli.7.4.540-548.2000
BibTeX
@article{Fahey2000,
author = {Fahey, J L and Aziz, N and Spritzler, J and Plaeger, S and Nishanian, P and Lathey, J L and Seigel, J and Landay, A L and Kilarui, R and Schmitz, J L and White, C and Wara, D W and Akridge, R and Cutili, J and Douglas, S D and Reuben, J and Shearer, W T and Nokta, M and Polland, R and Schooley, R and Asthana, D and Mizrachi, Y and Waxdal, M},
title = {Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation},
journal = {Clinical Diagnostic Laboratory Immunology},
year = {2000},
volume = {7},
number = {4},
pages = {540--548},
doi = {10.1128/cdli.7.4.540-548.2000}
}
EUVIMED